Cardiovascular outcomes across GLP-1/GIP agonists in a large, diverse real-world cohort: the INCRETIN-CV study
29 August 2026 (10:15 - 11:00)
Organised by: 
Abstract
Slides
About the speaker
Rabin Medical Centre, Petah Tikva (Israel)
7 More presentations in this session
Professor G. Fazio (Palermo, IT)
Doctor K. Katogiannis (Athens, GR)
Access the full session
The Event
ESC Congress 2026
29 August 2026
10:15 CET
You may be interested in
ESC Journals
Congress Presentation
Webinar
